# Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients

> **NCT06427291** · PHASE1 · RECRUITING · sponsor: **Fudan University** · enrollment: 20 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **BIOLOGICAL:** Herpes virus T3011 injection

## Key facts

- **NCT ID:** NCT06427291
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-21
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06427291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06427291, "Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06427291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*